Literature DB >> 8844126

Effects of basophil-priming and stimulating cytokines on histamine release from isolated human skin mast cells.

M Nitschke1, K Sohn, D Dieckmann, B F Gibbs, H H Wolff, U Amon.   

Abstract

Cell priming and stimulation of different cytokines (which include chemokines and growth factors) are typical features of human basophils. Recently, it has been shown that the macrophage chemotactic protein-1 (MCP-1), RANTES and macrophage inflammatory protein-1 alpha (MIP-1 alpha) are potent direct secretagogues for human basophils and that interleukin-3 (IL-3), IL-5 and granulocyte/macrophage colony-stimulating factor (GM-CSF) are priming factors for subsequent potentiation of mediator release from basophils induced by different stimuli. This observation may be clinically important for the activation and recruitment of inflammatory cells in different immune responses of the skin (e.g. late-phase reactions). The aim of the present study was to investigate whether cytokines and chemokines are also capable of priming or stimulating isolated human skin mast cells (SMC). SMC were either stimulated directly with the cytokines alone or preincubated with these factors for 10 min before being activated with suboptimal concentrations of anti-IgE, A23187 or substance P. IL-3, IL-5, GM-CSF, platelet factor-4 (PF-4), IL-8, MCP-1 and MIP-1 alpha (each at concentrations of 1 ng/ml to 1 microgram/ml, log steps) did not significantly modulate histamine release from SMC induced by the three different secretagogues. RANTES exhibited a weak but significant potentiating effect on IgE-mediated activation. Stem cell factor (SCF) as a positive control was able to prime mast cell histamine release strongly. In addition, PF-4, MCP-1, RANTES and MIP-1 alpha were incapable of inducing direct histamine release from SMC. In experiments with isolated human peripheral basophils, however, we observed potent Fc epsilon RI-mediated priming effects evoked through IL-3, IL-5 and GM-CSF. We conclude that SMC derived from healthy donors are not targets of (immuno)modulatory factors that prime or stimulate basophils.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8844126     DOI: 10.1007/bf02505236

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  29 in total

1.  CGP 41251, a novel protein kinase inhibitor with in vitro selectivity for protein kinase C, strongly inhibits immunological activation of human skin mast cells and human basophils.

Authors:  U Amon; E von Stebut; N Subramanian; H H Wolff
Journal:  Pharmacology       Date:  1993-09       Impact factor: 2.547

2.  The phenotype of human eosinophils, basophils, and mast cells.

Authors:  P Valent
Journal:  J Allergy Clin Immunol       Date:  1994-12       Impact factor: 10.793

3.  Macrophage inflammatory protein-1 alpha and monocyte chemoattractant peptide-1 elicit immediate and late cutaneous reactions and activate murine mast cells in vivo.

Authors:  R Alam; D Kumar; D Anderson-Walters; P A Forsythe
Journal:  J Immunol       Date:  1994-02-01       Impact factor: 5.422

4.  Interleukin-1 potentiates antigen-mediated arachidonic acid metabolite formation in mast cells.

Authors:  H Salari; M Chan-Yeung
Journal:  Clin Exp Allergy       Date:  1989-11       Impact factor: 5.018

5.  Monocyte chemotactic and activating factor is a potent histamine-releasing factor for basophils.

Authors:  R Alam; M A Lett-Brown; P A Forsythe; D J Anderson-Walters; C Kenamore; C Kormos; J A Grant
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

6.  Stimulation of histamine release from human basophils by human platelet factor 4.

Authors:  L L Brindley; J M Sweet; E J Goetzl
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

7.  Human recombinant granulocyte-macrophage colony-stimulating factor and interleukin 3 cause basophil histamine release.

Authors:  M Haak-Frendscho; N Arai; K Arai; M L Baeza; A Finn; A P Kaplan
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

8.  Stem cell factor is a chemotactic factor for human mast cells.

Authors:  G Nilsson; J H Butterfield; K Nilsson; A Siegbahn
Journal:  J Immunol       Date:  1994-10-15       Impact factor: 5.422

9.  Interleukin 5 modifies histamine release and leukotriene generation by human basophils in response to diverse agonists.

Authors:  S C Bischoff; T Brunner; A L De Weck; C A Dahinden
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

10.  Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects.

Authors:  A B Kay; S Ying; V Varney; M Gaga; S R Durham; R Moqbel; A J Wardlaw; Q Hamid
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

View more
  3 in total

Review 1.  Scratching the surface of allergic transfusion reactions.

Authors:  William J Savage; Aaron A R Tobian; Jessica H Savage; Robert A Wood; John T Schroeder; Paul M Ness
Journal:  Transfusion       Date:  2012-09-24       Impact factor: 3.157

2.  Distinct characteristics of signal transduction events by histamine-releasing factor/translationally controlled tumor protein (HRF/TCTP)-induced priming and activation of human basophils.

Authors:  Becky M Vonakis; Donald W Macglashan; Natalia Vilariño; Jacqueline M Langdon; Rebecca S Scott; Susan M MacDonald
Journal:  Blood       Date:  2007-11-27       Impact factor: 22.113

3.  Inhibition of stem cell factor reduces pulmonary cytokine levels during allergic airway responses.

Authors:  A A Berlin; P Lincoln; A Tomkinson; N W Lukacs
Journal:  Clin Exp Immunol       Date:  2004-04       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.